Elebsiran and PEG-IFNalpha for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial. Wong GL, Yuen MF, Lin B, Douglas MW, et al. Nat Med 2026;32:151-159.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wong GL, Yuen MF, Lin B, Douglas MW, et al. Elebsiran and PEG-IFNalpha for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial. Nat Med 2026;32:151-159.
PMID: 41203919